EB-FAPI or EB-FAPI+anti-PD-L1 antibody combination treated tumor mice raw sequence reads
MC38 tumor bearing mice were treated with EB-FAPI, EB-FAPI+anti-PD-L1 antibody, anti-PD-L1 antibody, or saline, respectively. After treatment with 1, 3 and 7 days, tumor tissues were collected and high throughput sequencing was performed. Saline untreated mice were used as control. Every treated group has 3 duplicates.